{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:05:42Z","timestamp":1790075142005,"version":"4.0.1"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pain Res."],"abstract":"<jats:p>Improved survival in sickle cell disease (SCD) has led to a growing population of older adults who experience a high burden of chronic pain. With aging, pain often shifts from episodic vaso-occlusive crises to persistent, multifactorial syndromes driven by cumulative tissue injury, central sensitization, and progressive organ damage. This evolution presents significant clinical challenges, particularly in the context of comorbidities, polypharmacy, and age-related physiological changes. This narrative review examines the epidemiology, pathophysiology, and management of chronic pain in aging adults with SCD. Key contributors to pain include musculoskeletal degeneration, neuropathic mechanisms, and chronic inflammation, compounded by renal, hepatic, and cardiovascular dysfunction. Pharmacological management requires careful consideration of analgesic safety, particularly with opioids, nonsteroidal anti-inflammatory drugs, and adjuvant agents. Nonpharmacological approaches, including rehabilitative and behavioral strategies, are essential components of care. Psychosocial factors and health disparities further influence pain experiences and treatment outcomes. A multidisciplinary, individualized approach integrating geriatric and SCD-specific principles is critical to improving quality of life in this vulnerable population.<\/jats:p>","DOI":"10.3389\/fpain.2026.1907108","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:31:23Z","timestamp":1790073083000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Chronic pain in the aging adult with sickle cell disease"],"prefix":"10.3389","volume":"7","author":[{"given":"Keesha","family":"Powell-Roach","sequence":"first","affiliation":[{"name":"Center for Sickle Cell Disease, University of Tennessee Health Science Center","place":["Memphis, TN, United States"]},{"name":"Rutgers Biomedical and Health Sciences, Rutgers University, Division of Nursing Science, School of Nursing","place":["Newark, NJ, United States"]},{"name":"Department of Health Promotion and Disease Prevention, University of Tennessee Health Science Center, College of Nursing","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugochi O.","family":"Ogu","sequence":"additional","affiliation":[{"name":"Center for Sickle Cell Disease, University of Tennessee Health Science Center","place":["Memphis, TN, United States"]},{"name":"Division of Hematology, University of Tennessee Health Science Center","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.4103\/ijmr.IJMR_1019_18","article-title":"Comorbidities in sickle cell disease: adult providers needed!","volume":"147","author":"Ogu","year":"2018","journal-title":"Indian J Med Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glae230","article-title":"Black Americans with sickle cell disease (SCD) demonstrate accelerated epigenetic pace of aging compared to black Americans without SCD","volume":"79","author":"Garrett","year":"2024","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/bloodadvances.2023011188","article-title":"Characterizing epigenetic aging in an adult sickle cell disease cohort","volume":"8","author":"L\u00ea","year":"2024","journal-title":"Blood Adv"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pathol.2016.10.002","article-title":"Sickle cell disease in the older adult","volume":"49","author":"Thein","year":"2017","journal-title":"Pathology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"E115","DOI":"10.1002\/ajh.25405","article-title":"A multi-institutional comparison of younger and older adults with sickle cell disease","volume":"94","author":"Oyedeji","year":"2019","journal-title":"Am J Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1182\/blood-2012-04-383430","article-title":"Sickle cell pain: a critical reappraisal","volume":"120","author":"Ballas","year":"2012","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1097\/j.pain.0000000000000824","article-title":"Sickle cell disease: a natural model of acute and chronic pain","volume":"158","author":"Brandow","year":"2017","journal-title":"Pain"},{"key":"B8","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jpain.2016.01.475","article-title":"An evaluation of central sensitization in patients with sickle cell disease","volume":"17","author":"Campbell","year":"2016","journal-title":"J Pain"},{"key":"B9","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1182\/hematology.2020000142","article-title":"Neuropathic pain in sickle cell disease: measurement and management","volume":"2020","author":"Glaros","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"Jama"},{"key":"B11","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.1182\/bloodadvances.2020001851","article-title":"American Society of hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain","volume":"4","author":"Brandow","year":"2020","journal-title":"Blood Adv"},{"key":"B12","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1001\/jamainternmed.2023.8538","article-title":"Opioid prescribing and outcomes in patients with sickle cell disease post-2016 CDC guideline","volume":"184","author":"Kang","year":"2024","journal-title":"JAMA Intern Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/15353702211068522","article-title":"Sickle cell disease as an accelerated aging syndrome","volume":"247","author":"Idris","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/s0140-6736(17)30193-9","article-title":"Sickle cell disease","volume":"390","author":"Ware","year":"2017","journal-title":"Lancet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"E584","DOI":"10.1002\/ajh.24855","article-title":"Prospective evaluation of chronic organ damage in adult sickle cell patients: a seven-year follow-up study","volume":"92","author":"Van Tuijn","year":"2017","journal-title":"Am J Hematol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/2049463720920682","article-title":"Mechanisms of pain in sickle cell disease","volume":"15","author":"Takaoka","year":"2021","journal-title":"Br J Pain"},{"key":"B17","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1182\/hematology.2019000038","article-title":"Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management","volume":"2019","author":"Adesina","year":"2019","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4070547","article-title":"Comorbidity, pain, utilization, and psychosocial outcomes in older versus younger sickle cell adults: the PiSCES project","volume":"2017","author":"McClish","year":"2017","journal-title":"BioMed Res Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/pbc.24838","article-title":"Neuropathic pain in patients with sickle cell disease","volume":"61","author":"Brandow","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jpainsymman.2011.06.020","article-title":"Detecting the emergence of chronic pain in sickle cell disease","volume":"43","author":"Hollins","year":"2012","journal-title":"J Pain Symptom Manage"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00277-017-2984-z","article-title":"Neuropathic pain in patients with sickle cell disease: a cross-sectional study assessing teens and young adults","volume":"96","author":"Antunes","year":"2017","journal-title":"Ann Hematol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1093\/pm\/pnad133","article-title":"Altered pain processing and sensitization in sickle cell disease: a scoping review of quantitative sensory testing findings","volume":"25","author":"Kenney","year":"2024","journal-title":"Pain Medicine"},{"key":"B23","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.jpain.2019.11.002","article-title":"Sensitivities to thermal and mechanical stimuli: adults with sickle cell disease compared to healthy, pain-free African American controls","volume":"21","author":"Molokie","year":"2020","journal-title":"J Pain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1097\/ajp.0000000000001119","article-title":"Adolescents and young adults with sickle cell disease: nociplastic pain and pain catastrophizing as predictors of pain interference and opioid consumption","volume":"39","author":"Kuisell","year":"2023","journal-title":"Clin J Pain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.amepre.2016.02.012","article-title":"Chronic opioid therapy and central sensitization in sickle cell disease","volume":"51","author":"Carroll","year":"2016","journal-title":"Am J Prev Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jpain.2016.12.016","article-title":"AAPT Diagnostic criteria for chronic sickle cell disease pain","volume":"18","author":"Dampier","year":"2017","journal-title":"J Pain"},{"key":"B27","doi-asserted-by":"publisher","first-page":"101107","DOI":"10.1016\/j.dhjo.2021.101107","article-title":"Health-related quality of life and neuropathic pain in sickle cell disease in Jamaica","volume":"14","author":"Bartlett","year":"2021","journal-title":"Disabil Health J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ajh.24134","article-title":"Critical reviews: how we treat sickle cell patients with leg ulcers","volume":"91","author":"Minniti","year":"2016","journal-title":"Am J Hematol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1182\/bloodadvances.2017006940","article-title":"Depression, quality of life, and medical resource utilization in sickle cell disease","volume":"1","author":"Adam","year":"2017","journal-title":"Blood Adv"},{"key":"B30","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.transci.2019.04.029","article-title":"Chronic pain persists in adults with sickle cell disease despite regular red cell transfusions","volume":"58","author":"Karafin","year":"2019","journal-title":"Transfus Apher Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.cnur.2017.08.001","article-title":"Pain management in older adults","volume":"52","author":"Horgas","year":"2017","journal-title":"Nurs Clin North Am"},{"key":"B33","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1001\/jama.2014.9405","article-title":"Management of persistent pain in the older patient: a clinical review","volume":"312","author":"Makris","year":"2014","journal-title":"Jama"},{"key":"B34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.amjopharm.2012.09.004","article-title":"Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics","volume":"10","author":"O'Neil","year":"2012","journal-title":"Am J Geriatr Pharmacother"},{"key":"B35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40266-023-01014-8","article-title":"Management of older adults with sickle cell disease: considerations for current and emerging therapies","volume":"40","author":"Oyedeji","year":"2023","journal-title":"Drugs Aging"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics society 2023 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"Jama"},{"key":"B38","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1182\/blood.V130.Suppl_1.130.130","article-title":"Opioid utilization patterns in United States patients with sickle cell disease","volume":"130","author":"Ballas","year":"2017","journal-title":"Blood"},{"key":"B39","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.4065\/mcp.2009.0646","article-title":"Treatment considerations for elderly and frail patients with neuropathic pain","volume":"85","author":"Schmader","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/gerona\/glaa038","article-title":"Opioid use and the risk of falls, fall injuries and fractures among older adults: a systematic review and meta-analysis","volume":"75","author":"Yoshikawa","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B41","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1182\/asheducation-2017.1.435","article-title":"Chronic organ failure in adult sickle cell disease","volume":"2017","author":"Vichinsky","year":"2017","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B42","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1182\/hematology.2020000143","article-title":"Optimizing the management of chronic pain in sickle cell disease","volume":"2020","author":"Osunkwo","year":"2020","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"B43","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.3390\/jcm9123902","article-title":"Considerations for Cannabis use to treat pain in sickle cell disease","volume":"9","author":"Argueta","year":"2020","journal-title":"J Clin Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/can.2019.0036","article-title":"Daily Cannabis users with sickle cell disease show fewer admissions than others with similar pain complaints","volume":"5","author":"Curtis","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"key":"B45","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1182\/blood.2022016382","article-title":"Cannabidiol attenuates hyperalgesia in a mouse model of sickle cell disease","volume":"141","author":"Cherukury","year":"2023","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2026.300736","article-title":"Emerging preclinical evidence supports a potential role for cannabidiol in the management of sickle cell disease","author":"De Kreuk","year":"2020","journal-title":"Haematologica"},{"key":"B47","doi-asserted-by":"publisher","first-page":"Cd012943","DOI":"10.1002\/14651858.CD012943.pub2","article-title":"Interventions for treating neuropathic pain in people with sickle cell disease","volume":"7","author":"Asnani","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"B48","doi-asserted-by":"publisher","first-page":"939","DOI":"10.7326\/0003-4819-148-12-200806170-00221","article-title":"Systematic review: hydroxyurea for the treatment of adults with sickle cell disease","volume":"148","author":"Lanzkron","year":"2008","journal-title":"Ann Intern Med"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1001\/jama.289.13.1645","article-title":"Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment","volume":"289","author":"Steinberg","year":"2003","journal-title":"Jama"},{"key":"B50","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jpainsymman.2015.10.017","article-title":"Sickle cell disease: a review of nonpharmacological approaches for pain","volume":"51","author":"Williams","year":"2016","journal-title":"J Pain Symptom Manage"},{"key":"B52","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/j.pain.0000000000003009","article-title":"A cognitive-behavioral digital health intervention for sickle cell disease pain in adolescents: a randomized, controlled, multicenter trial","volume":"165","author":"Palermo","year":"2024","journal-title":"Pain"},{"key":"B53","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1136\/bjsports-2021-104450","article-title":"Safety of maximal cardiopulmonary exercise testing in individuals with sickle cell disease: a systematic review","volume":"56","author":"Smith","year":"2022","journal-title":"Br J Sports Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.pmn.2018.10.002","article-title":"Acceptability and feasibility of a mindfulness-based intervention for pain catastrophizing among persons with sickle cell disease","volume":"20","author":"Simmons","year":"2019","journal-title":"Pain Manag Nurs"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/jpepsy\/jsp015","article-title":"A randomized controlled trial of massage therapy in children with sickle cell disease","volume":"34","author":"Lemanek","year":"2009","journal-title":"J Pediatr Psychol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1177\/09645284211017303","article-title":"Acupuncture for chronic pain in adults with sickle cell disease: a mixed-methods pilot study","volume":"39","author":"Li","year":"2021","journal-title":"Acupunct Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/ajp.0000000000000036","article-title":"A retrospective review of acupuncture use for the treatment of pain in sickle cell disease patients: descriptive analysis from a single institution","volume":"30","author":"Lu","year":"2014","journal-title":"Clin J Pain"},{"key":"B58","doi-asserted-by":"publisher","first-page":"102287","DOI":"10.1016\/j.ctim.2019.102287","article-title":"Acupuncture for pain management in children with sickle cell disease","volume":"49","author":"Mahmood","year":"2020","journal-title":"Complement Ther Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"Cd012762","DOI":"10.1002\/14651858.CD012762.pub2","article-title":"Transcutaneous electrical nerve stimulation (TENS) for pain management in sickle cell disease","volume":"3","author":"Pal","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e2314070","DOI":"10.1001\/jamanetworkopen.2023.14070","article-title":"Examining mental health, education, employment, and pain in sickle cell disease","volume":"6","author":"Harris","year":"2023","journal-title":"JAMA Netw Open"},{"key":"B61","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/bjh.18981","article-title":"Psychiatric comorbidities in adults with sickle cell disease: a narrative review","volume":"203","author":"Mishkin","year":"2023","journal-title":"Br J Haematol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1080\/01612840.2018.1443530","article-title":"Stigma of sickle cell disease: a systematic review","volume":"39","author":"Bulgin","year":"2018","journal-title":"Issues Ment Health Nurs"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/bjh.19243","article-title":"Mental health, pain and likelihood of opioid misuse among adults with sickle cell disease","volume":"204","author":"Jonassaint","year":"2024","journal-title":"Br J Haematol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.amjmed.2019.06.014","article-title":"Opioid management in older adults with chronic kidney disease: a review","volume":"132","author":"Owsiany","year":"2019","journal-title":"Am J Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.15585\/mmwr.mm6646a2","article-title":"CDC Grand rounds: improving the lives of persons with sickle cell disease","volume":"66","author":"Hulihan","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"B66","first-page":"1069","article-title":"Management of sickle cell disease: recommendations from the 2014 expert panel report","volume":"92","author":"Yawn","year":"2015","journal-title":"Am Fam Physician"},{"key":"B67","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.genhosppsych.2021.01.009","article-title":"The role of social isolation in physical and emotional outcomes among patients with chronic pain","volume":"69","author":"Bannon","year":"2021","journal-title":"Gen Hosp Psychiatry"},{"key":"B68","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1177\/2049463718802868","article-title":"Association between musculoskeletal pain with social isolation and loneliness: analysis of the English longitudinal study of ageing","volume":"13","author":"Smith","year":"2019","journal-title":"Br J Pain"},{"key":"B69","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1111\/bjh.18386","article-title":"A case-control and seven-year longitudinal neurocognitive study of adults with sickle cell disease in Ghana","volume":"199","author":"Ampomah","year":"2022","journal-title":"Br J Haematol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.arr.2011.03.003","article-title":"Aging with multimorbidity: a systematic review of the literature","volume":"10","author":"Marengoni","year":"2011","journal-title":"Ageing Res Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/epirev\/mxs009","article-title":"Multimorbidity in older adults","volume":"35","author":"Salive","year":"2013","journal-title":"Epidemiol Rev"},{"key":"B72","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1056\/NEJMc1706325","article-title":"Sickle cell disease","volume":"377","author":"Piel","year":"2017","journal-title":"N Engl J Med"},{"key":"B73","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1197\/j.aem.2006.11.033","article-title":"Emergency department management of acute pain episodes in sickle cell disease","volume":"14","author":"Tanabe","year":"2007","journal-title":"Acad Emerg Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/AJP.0b013e3181bed10c","article-title":"A comparison of analgesic management for emergency department patients with sickle cell disease and renal colic","volume":"26","author":"Lazio","year":"2010","journal-title":"Clin J Pain"},{"key":"B75","doi-asserted-by":"publisher","first-page":"3804","DOI":"10.1182\/bloodadvances.2020001743","article-title":"Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects","volume":"4","author":"Kanter","year":"2020","journal-title":"Blood Adv"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.hoc.2022.08.008","article-title":"Structural racism and impact on sickle cell disease: sickle cell lives matter","volume":"36","author":"Smith","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical practice guideline for prescribing opioids for pain\u2014united States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"B78","doi-asserted-by":"publisher","first-page":"e508","DOI":"10.1016\/s2352-3026(20)30183-6","article-title":"Addressing bias towards patients with sickle cell disease","volume":"7","author":"DeLaune","year":"2020","journal-title":"Lancet Haematol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jnma.2025.12.008","article-title":"Implicit bias in pain management: the intersection of stigma, race, and chronic disease in sickle cell disease","volume":"118","author":"Edwards","year":"2026","journal-title":"J Natl Med Assoc"},{"key":"B80","doi-asserted-by":"publisher","first-page":"e2450172","DOI":"10.1001\/jamanetworkopen.2024.50172","article-title":"Biased language in simulated handoffs and clinician recall and attitudes","volume":"7","author":"Wesevich","year":"2024","journal-title":"JAMA Netw Open"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1007\/s40615-024-02153-3","article-title":"Perceptions of care and perceived discrimination: a qualitative assessment of adults living with sickle cell disease","volume":"12","author":"Crusto","year":"2025","journal-title":"J Racial Ethn Health Disparities"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e050880","DOI":"10.1136\/bmjopen-2021-050880","article-title":"Identifying barriers to evidence-based care for sickle cell disease: results from the sickle cell disease implementation consortium cross-sectional survey of healthcare providers in the USA","volume":"11","author":"Smeltzer","year":"2021","journal-title":"BMJ Open"},{"key":"B83","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.pmn.2012.10.007","article-title":"Care seeking for pain in young adults with sickle cell disease","volume":"15","author":"Jenerette","year":"2014","journal-title":"Pain Manag Nurs"}],"container-title":["Frontiers in Pain Research"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2026.1907108\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:31:24Z","timestamp":1790073084000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpain.2026.1907108\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":83,"alternative-id":["10.3389\/fpain.2026.1907108"],"URL":"https:\/\/doi.org\/10.3389\/fpain.2026.1907108","relation":{},"ISSN":["2673-561X"],"issn-type":[{"value":"2673-561X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1907108"}}